title: [Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease].
authors.forename: Marina
authors.initials: M
authors.lastname: Millán
authors.forename: Manuel
authors.initials: M
authors.lastname: Castro-Fernández
authors.forename: Javier
authors.initials: J
authors.lastname: Ampuero
authors.forename: Manuel
authors.initials: M
authors.lastname: Romero-Gómez
mesh_terms: D000368:Aged; D000493:Allopurinol / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001711:Biotransformation / Q000187:drug effects; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D003424:Crohn Disease / Q000188:drug therapy*; D004347:Drug Interactions; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D015122:Mercaptopurine / Q000378:metabolism / Q000493:pharmacokinetics; D008780:Methyltransferases / Q000037:antagonists & inhibitors / Q000502:physiology; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D007166:Immunosuppressive Agents; D000493:Allopurinol; D015122:Mercaptopurine; D014969:Xanthine Oxidase; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine